Shingles is a painful, blistering rash caused by the
reactivation of the Varicella Zoster Virus (VZV) – the same virus that causes
chickenpox. After a person recovers from chickenpox, the virus remains in the
body and can reactivate later in life.
About 1 in 3 people will develop shingles, usually after age
50 or with a weakened immune system.
Shingles typically lasts a few weeks, but it can lead to
serious complications like:
- Long-term nerve pain
(post-herpetic neuralgia) - Vision or hearing loss
- Neurological issues
Who should be vaccinated?
Health authorities recommended shingles vaccination for:
- Adults over 50 or 60, depending
on your country - People with weakened immune
systems - Those seeking to prevent future
complications
Even if you have had shingles, vaccination is still
recommended – just wait 12 months after recovery.
What vaccine is available?
Shingrix, a non-live vaccine, is the most recommended option
and is given in two doses. Availability and cost vary by country, with some
offering free or subsidised vaccines for eligible groups.
For more information, visit the World Health Organization: who.int/news-room/fact-sheets/detail/shingles-(herpes-zoster)
Talk to your healthcare provider to see if the vaccine is right for you.